Record overview
Status and phase
Status: RECRUITING
Phase: PHASE1, PHASE2
Sponsor: Qilu Pharmaceutical Co., Ltd.
Condition: Advanced Solid Tumor
NCT06911827
A Study of QLP2117 in Combination With QL2107 in Advanced Solid Tumor Patients
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: few_sites_large_trial_signal | strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.